|
|
Article: Ciba-Geigy's U.S. generics arm goes head to head with ICI's Tenormin. (Geneva Pharmaceuticals receives approval to market atenolol, generic version of Imperial Chemical Industries PLC's antihypertensive drug Tenormin)(News) (Brief Article)
- Article from:
- Chemical Week
- Article date:
- October 2, 1991
- Author:
CopyrightCOPYRIGHT 1991 Access Intelligence, LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Ciba-Geigy's (Basel) generics firm, Geneva Pharmaceuticals (Broomfield, CO), has received Food & Drug Administration (Washington) approval to make and sell atenolol, its generic version of ICI's antihypertensive drug Tenormin, in the U.S. ICI's U.S. patent covering treatment of angina with Tenormin expired last week. ICI's patent for use against hypertension, which covers the bulk of sales, continues until 1993.
ICI's sales of the beta-blocker amounted to 650 million pounds ($1.1 billion) in 1990, almost half generated in the U.S. The angina market accounts for 15% of U.S. Tenormin sales. Observers foresee a $170-million/year dent in ICI Pharmaceuticals' sales ...
Related newspaper, magazine, and journal articles:
|
|
Article: Geneva Pharmaceuticals, Inc. Names President and ...
PR Newswire;
January 5, 1999 ;
700+ words
... ... Jan. 5 /PRNewswire/ -- Geneva Pharmaceuticals appointed David M. Hurley to the ... Management. A Novartis AG Company, Geneva Pharmaceuticals maintains a strong position in ... December 31, 1998 having lead Geneva Pharmaceuticals for the past 10 years. Novartis ...
|
|